Glucotrack announces 1:60 reverse stock split

Glucotrack, Inc. (GCTK) completed a 1-for-60 reverse stock split on June 16, 2025, reducing outstanding shares from approximately 34.05 million to about 567,456, following stockholder approval. The reverse split aims to enhance marketability and meet Nasdaq's minimum bid price requirement, driven by a 98% stock decline over the past six months. Despite a healthy current ratio of 4.85, the company faces challenges including a $15.05 million negative EBITDA and a potential Nasdaq delisting, though they plan to appeal.

Analysis

Glucotrack, Inc. (NASDAQ:GCTK) has executed a 1-for-60 reverse stock split, effective for trading on June 16, 2025, reducing its outstanding common shares from approximately 34.05 million to about 567,456. This stockholder-approved action aims to address a critical 98% stock price decline over the past six months and regain compliance with Nasdaq's $1.00 minimum bid price, thereby mitigating delisting risk, a process the company intends to appeal if necessary. Despite a current market capitalization of only $2.53 million and a significant negative EBITDA of $15.05 million in the last twelve months, Glucotrack exhibits strong short-term liquidity with a current ratio of 4.85 and holds more cash than debt on its balance sheet. Technical indicators from InvestingPro suggest the stock's Relative Strength Index (RSI) is in oversold territory; however, the company faces substantial fundamental challenges. Glucotrack is pursuing strategic initiatives, including the appointment of Dr. Victoria E. Carr-Brendel to its Board for her medical device expertise and a partnership with OneTwo Analytics to leverage AI for enhancing its Continuous Blood Glucose Monitor clinical study data, reflecting efforts to navigate its precarious financial and operational situation.

Key Decisions for Investors

• Investors should exercise extreme caution with Glucotrack (GCTK) due to its severe stock depreciation, negative EBITDA, and ongoing Nasdaq delisting risk, as reverse stock splits are often indicative of significant underlying financial distress.
• Closely monitor crucial developments including the outcome of any Nasdaq delisting appeal, the stock's post-split trading behavior regarding liquidity and price stability, and tangible progress from strategic initiatives such as the OneTwo Analytics partnership and new board member contributions.
• While short-term liquidity appears robust with a current ratio of 4.85 and a favorable cash-to-debt position, the substantial negative EBITDA necessitates careful scrutiny of future financial reports for cash burn rates and any path to profitability to assess long-term viability.